Evaluation of co-registration impact on differentiating benign and malignant breast lesions using MRI, indicating improved classification accuracy.
Objective To evaluate if co-registering Diffusion-Weighted Imaging (DWI) before generating Apparent Diffusion Coefficient (ADC) maps can improve differentiating benign and malignant breast lesions in MRI based on the A6702 thresholds. Materials and methods This IRB-approved study involved an in-house dataset and the publicly available ACRIN-6698 dataset, both including multi b -value DWI. In phase one, 16 ANTs library-based co-registration methods were evaluated on a subset of n = 138 cases from our in-house cohort. The quantitative assessment included mean ADC values of manually segmented lesions (diagnostic metrics using individual and A6702-defined thresholds) and coefficient of Variation. In the second phase, the best-performing methods were tested for generalizability on an unseen set of 40 cases (20 from in-house and 20 from external dataset). Three blinded readers segmented lesions on co-registered and non-co-registered ADC maps. Agreement and consistency were evaluated via Bland–Altman, segmentation distance, and intraclass correlation coefficient. Results Rigid co-registration using DWI at b = 750 s/mm 2 as reference (b750-Rigid) improved accuracy of both optimal/conservative A6702 trial thresholds with sensitivity/specificity increasing from 93%/10% to 97%/30% and 100%/30% respectively. Mean ADC values were not significantly different after co-registration ( p > 0.05). Discussion Co-registration of DWI images before ADC map generation, particularly using b750-Rigid registration, seems promising for improving lesion classification in breast MRI. Further validation is warranted.
No takes yet. Share an insight, caveat, or question.
Brock et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: